Literature DB >> 21189274

Nonfasting lipids, lipoproteins, and apolipoproteins in individuals with and without diabetes: 58 434 individuals from the Copenhagen General Population Study.

Anne Langsted1, Børge G Nordestgaard.   

Abstract

BACKGROUND: Whether lipid profiles should be collected from fasting or nonfasting individuals is controversial, particularly in the diabetic population. We examined the influence of normal food intake on lipid profiles in diabetic and nondiabetic individuals.
METHODS: We assessed plasma concentrations of lipids, lipoproteins, apolipoproteins, and albumin as a function of time since the last meal in 58 434 individuals (participation rate 45%) from the general population, 2270 of whom had diabetes mellitus.
RESULTS: Similar patterns in the measured constituents were observed in the diabetic and nondiabetic populations. Triglycerides remained increased for 6-7 h in both populations after the last meal, whereas LDL cholesterol and albumin but not apolipoprotein B were reduced in both populations up to 5 h after normal food intake; after adjustment for hemodilution on the basis of albumin concentrations, the LDL cholesterol reductions were no longer present. Maximum observed mean differences from fasting concentrations in diabetic patients were -0.6 mmol/L, 0 mmol/L, 0.2 mmol/L, and 0.08 g/L (8 mg/dL) for LDL cholesterol, HDL cholesterol, triglycerides, and apolipoprotein B, respectively, and, correspondingly, -0.3 mmol/L, 0 mmol/L, 0.2 mmol/L, and 0.03 g/L (3 mg/dL) in individuals without diabetes.
CONCLUSIONS: Triglycerides increased up to 0.2 mmol/L after normal food intake in individuals with and without diabetes, whereas the postprandial reductions in LDL cholesterol observed in both populations likely were caused by hemodilution due to fluid intake. No statistically significant differences in postprandial apolipoprotein B concentrations were found. These data may be useful for discussion during revisions of guidelines for lipid measurements in individuals with or without diabetes.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21189274     DOI: 10.1373/clinchem.2010.157164

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  27 in total

1.  PURLs: skip this step when checking lipid levels.

Authors:  Michael Wootten; Debra B Stulberg; Shailendra Prasad; Kate Rowland
Journal:  J Fam Pract       Date:  2015-02       Impact factor: 0.493

Review 2.  Peripheral arterial disease, type 2 diabetes and postprandial lipidaemia: Is there a link?

Authors:  Pedro Valdivielso; José Ramírez-Bollero; Carmen Pérez-López
Journal:  World J Diabetes       Date:  2014-10-15

3.  Influence of HbA1c and BMI on Lipid Trajectories in Youths and Young Adults With Type 1 Diabetes.

Authors:  Michelle L Katz; Craig R Kollman; Carly E Dougher; Mohamed Mubasher; Lori M B Laffel
Journal:  Diabetes Care       Date:  2016-10-20       Impact factor: 19.112

4.  Fasting might not be necessary before lipid screening: a nationally representative cross-sectional study.

Authors:  Michael J Steiner; Asheley Cockrell Skinner; Eliana M Perrin
Journal:  Pediatrics       Date:  2011-08-01       Impact factor: 7.124

5.  Non-fasting lipid profile for cardiovascular risk assessments using China ASCVD risk estimator and Europe SCORE risk charts in Chinese participants.

Authors:  Shi-Lan Zhang; Xiao Du; Jin Xu; Qun-Yan Xiang; Ling Liu
Journal:  Cardiovasc Diagn Ther       Date:  2021-08

6.  Impact of glucose and lipid markers on the correlation of calculated and enzymatic measured low-density lipoprotein cholesterol in diabetic patients with coronary artery disease.

Authors:  Qiu-Ting Dong; Ying Gao; Na-Qiong Wu; Yuan-Lin Guo; Cheng-Gang Zhu; Sha Li; Hui-Hui Liu; Ye-Xuan Cao; Hui-Wen Zhang; Xi Zhao; Geng Liu; Qian Dong; Jian-Jun Li
Journal:  J Clin Lab Anal       Date:  2018-01-30       Impact factor: 2.352

Review 7.  Update on the NCEP ATP-III emerging cardiometabolic risk factors.

Authors:  Robert H Eckel; Marc-Andre Cornier
Journal:  BMC Med       Date:  2014-08-26       Impact factor: 8.775

8.  Association Between Paradoxical HDL Cholesterol Decrease and Risk of Major Adverse Cardiovascular Events in Patients Initiated on Statin Treatment in a Primary Care Setting.

Authors:  Pål Hasvold; Marcus Thuresson; Johan Sundström; Niklas Hammar; Sverre E Kjeldsen; Gunnar Johansson; Ingar Holme; Johan Bodegård
Journal:  Clin Drug Investig       Date:  2016-03       Impact factor: 2.859

Review 9.  The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and management.

Authors:  Robert A Hegele; Henry N Ginsberg; M John Chapman; Børge G Nordestgaard; Jan Albert Kuivenhoven; Maurizio Averna; Jan Borén; Eric Bruckert; Alberico L Catapano; Olivier S Descamps; G Kees Hovingh; Steve E Humphries; Petri T Kovanen; Luis Masana; Päivi Pajukanta; Klaus G Parhofer; Frederick J Raal; Kausik K Ray; Raul D Santos; Anton F H Stalenhoef; Erik Stroes; Marja-Riitta Taskinen; Anne Tybjærg-Hansen; Gerald F Watts; Olov Wiklund
Journal:  Lancet Diabetes Endocrinol       Date:  2013-12-23       Impact factor: 32.069

10.  The Role of Fasting LDL-C Levels in Their Non-fasting Reduction in Patients With Coronary Heart Disease.

Authors:  Qiuzhen Lin; Yan Fu; XueYan Zang; Qiming Liu; Ling Liu
Journal:  Front Cardiovasc Med       Date:  2021-06-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.